The US Food and Drug Administration (FDA) has given an emergency use authorization to the first commercial laboratory test to detect neutralizing antibodies against SARS-CoV-2, the virus that causes ...
(Reuters) - LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus. Information from the test about the ...
Piscataway-based GenScript USA Inc. said Monday that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the cPass™ SARS-CoV-2 Neutralization Antibody Detection ...
Neutralizing antibody titers have been found to be strongly correlated with observed vaccine effectiveness against symptomatic and severe COVID-19. Few non-high complexity assays are currently ...
Vaccinations against the SARS-CoV-2 are still crucial in combating the ongoing pandemic that has caused more than 700 million infections and claimed almost 7 million lives in the past four years.
WASHINGTON, D.C. — More than 50 million people in the country are now fully vaccinated against COVID-19. "Most of America is already speeding towards normalcy," said former Baltimore Health ...
Researchers from the Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, along with multiple collaborators, have developed a compact diagnostic platform that can evaluate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results